Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Feb 7;44(6):513-515.
doi: 10.1093/eurheartj/ehac749.

Prognostic interpretation of serial high-sensitivity cardiac troponin in patients presenting with suspected acute coronary syndrome

David A Morrow  1
Affiliations
Editorial

Prognostic interpretation of serial high-sensitivity cardiac troponin in patients presenting with suspected acute coronary syndrome

David A Morrow. Eur Heart J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Dr. Morrow reports grants to the Brigham and Women’s Hospital from Abbott Laboratories, Amgen, Anthos Therapeutics, AstraZeneca, Eisai, Medicines Co., Merck, Novartis, Pfizer, Roche Diagnostics, and Siemens, and consultant fees from Abbott Laboratories, InCardia, Inflammatix, Merck & Co, Novartis, and Roche Diagnostics. Dr. Morrow is a member of the TIMI Study Group, which has received institutional research grant support through Brigham and Women's Hospital from Abbott, Amgen, Anthos Therapeutics, ARCA Biopharma, AstraZeneca, Bayer, Daiichi-Sankyo, Eisai, Intarcia, Ionis Pharmaceuticals, Merck, Novartis, Pfizer, Regeneron Pharmaceuticals, Roche, and Siemens Healthcare Diagnostics.

Comment on

  • Serial troponin-T and long-term outcomes in suspected acute coronary syndrome.
    Pareek M, Kragholm KH, Kristensen AMD, Vaduganathan M, Pallisgaard JL, Byrne C, Biering-Sørensen T, Lee CJ, Bonde AN, Mortensen MB, Maeng M, Fosbøl EL, Køber L, Olsen NT, Gislason GH, Bhatt DL, Torp-Pedersen C. Pareek M, et al. Eur Heart J. 2023 Feb 7;44(6):502-512. doi: 10.1093/eurheartj/ehac629. Eur Heart J. 2023. PMID: 36329643